This site is intended for healthcare professionals only
LoginRegister
Biocon, NCSM partnerBiocon Biologics secures multiple market access agreements in US for Yesintek
WHO plans to back use of weight-loss drugs for adults globallyWHO to back use of weight-loss drugs as obesity treatment in adults
Batch of Telma AM earlier classified as NSQ now flagged as SpuriousBatch of Tofajak Tablets earlier classified as NSQ now flagged as Spurious
AstraZeneca Datroway gets USFDA accelerated nod for previously treated advanced EGFR-mutated non-small cell lung cancerCDSCO Panel Approves AstraZeneca's Protocol Amendment for Anti-cancer Drug AZD0901 study
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterationsJohnson and Johnson Gets CDSCO Panel nod for Additional Indication of Ustekinumab solution for...
Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancerEMA Committee recommends EU label update for Roche Phesgo to allow administration outside of...
Bayer gets UK nod for Lynkuet for moderate to severe vasomotor symptoms associated with menopauseBayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular...
AstraZeneca Pharma India receives CDSCO nod for expanded use of Imfinzi in bladder cancerAstraZeneca Breztri met primary endpoints in Phase III trials in asthma
Not a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent RestrictionsNot a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent Restrictions
Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, EuropeCDSCO Panel Approves Dr Reddy's Laboratories Protocol Amendment Proposal to study Abatacept
CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III TrialCDSCO Panel Approves Novartis Healthcare's Protocol Amendment to study Iptacopan
Rajasthan govt set to revive Rajasthan Drugs and PharmaRajasthan govt set to revive Rajasthan Drugs and Pharma
X